(SLG) SL Green Realty - Overview
Stock: Office, Retail, Mixed-Use, Debt, Equity
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.59% |
| Yield on Cost 5y | 5.55% |
| Yield CAGR 5y | -17.35% |
| Payout Consistency | 93.1% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 36.0% |
| Relative Tail Risk | -0.15% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.97 |
| Alpha | -47.45 |
| Character TTM | |
|---|---|
| Beta | 1.093 |
| Beta Downside | 1.286 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.89% |
| CAGR/Max DD | 0.22 |
Description: SLG SL Green Realty January 10, 2026
SL Green Realty Corp. (NYSE:SLG) is Manhattan’s largest office landlord and operates as a fully integrated REIT focused on acquiring, managing, and enhancing the value of commercial properties in the borough. As of September 30 2025, the company owned interests in 53 buildings covering 30.7 million sq ft, including direct ownership of 27.1 million sq ft and 2.7 million sq ft held through debt and preferred-equity investments.
Key metrics that shape SL Green’s outlook include: (1) an occupancy rate of roughly 93 % in Q2 2024, reflecting a modest rebound in Manhattan office demand after the pandemic-driven vacancy peak; (2) funds-from-operations (FFO) growth of 5-6 % year-over-year, driven by rent escalations on newly-leased space and cost-saving initiatives; and (3) a leverage ratio of about 5.2×, which remains within the REIT’s covenant thresholds but is sensitive to rising Treasury yields that influence borrowing costs. The broader office sector is also being affected by the ongoing shift toward hybrid work models and the health of the financial services industry, which historically underpins a large share of Manhattan’s office tenancy.
For a deeper quantitative dive, you may want to explore ValueRay’s interactive dashboard to see how these drivers play out in real-time.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -88.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -0.98 > 1.0 |
| NWC/Revenue: 22.48% < 20% (prev 104.2%; Δ -81.68% < -1%) |
| CFO/TA 0.01 > 3% & CFO 90.2m > Net Income -88.3m |
| Net Debt (7.57b) to EBITDA (320.1m): 23.65 < 3 |
| Current Ratio: 2.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (70.5m) vs 12m ago -3.36% < -2% |
| Gross Margin: 34.08% > 18% (prev 0.36%; Δ 3372 % > 0.5%) |
| Asset Turnover: 9.31% > 50% (prev 6.75%; Δ 2.56% > 0%) |
| Interest Coverage Ratio: 0.40 > 6 (EBITDA TTM 320.1m / Interest Expense TTM 161.0m) |
Altman Z'' -0.16
| A: 0.02 (Total Current Assets 446.1m - Total Current Liabilities 220.7m) / Total Assets 11.08b |
| B: -0.07 (Retained Earnings -741.9m / Total Assets 11.08b) |
| C: 0.01 (EBIT TTM 64.4m / Avg Total Assets 10.78b) |
| D: -0.11 (Book Value of Equity -763.4m / Total Liabilities 6.73b) |
| Altman-Z'' Score: -0.16 = B |
Beneish M -3.27
| DSRI: 0.22 (Receivables 328.5m/1.05b, Revenue 1.00b/706.6m) |
| GMI: 1.05 (GM 34.08% / 35.75%) |
| AQI: 1.12 (AQ_t 0.88 / AQ_t-1 0.79) |
| SGI: 1.42 (Revenue 1.00b / 706.6m) |
| TATA: -0.02 (NI -88.3m - CFO 90.2m) / TA 11.08b) |
| Beneish M-Score: -3.27 (Cap -4..+1) = AA |
What is the price of SLG shares?
Over the past week, the price has changed by -2.37%, over one month by -10.12%, over three months by -12.55% and over the past year by -31.45%.
Is SLG a buy, sell or hold?
- StrongBuy: 2
- Buy: 2
- Hold: 13
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the SLG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 53.7 | 22.8% |
| Analysts Target Price | 53.7 | 22.8% |
| ValueRay Target Price | 44.8 | 2.5% |
SLG Fundamental Data Overview February 02, 2026
P/S = 3.3933
P/B = 0.9238
P/EG = 0.9462
Revenue TTM = 1.00b USD
EBIT TTM = 64.4m USD
EBITDA TTM = 320.1m USD
Long Term Debt = 5.07b USD (from longTermDebt, last quarter)
Short Term Debt = 913.4m USD (from shortTermDebt, last quarter)
Debt = 7.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.57b USD (from netDebt column, last quarter)
Enterprise Value = 11.15b USD (3.40b + Debt 7.91b - CCE 155.7m)
Interest Coverage Ratio = 0.40 (Ebit TTM 64.4m / Interest Expense TTM 161.0m)
EV/FCF = 393.4x (Enterprise Value 11.15b / FCF TTM 28.4m)
FCF Yield = 0.25% (FCF TTM 28.4m / Enterprise Value 11.15b)
FCF Margin = 2.83% (FCF TTM 28.4m / Revenue TTM 1.00b)
Net Margin = -8.80% (Net Income TTM -88.3m / Revenue TTM 1.00b)
Gross Margin = 34.08% ((Revenue TTM 1.00b - Cost of Revenue TTM 661.3m) / Revenue TTM)
Gross Margin QoQ = -43.91% (prev 84.63%)
Tobins Q-Ratio = 1.01 (Enterprise Value 11.15b / Total Assets 11.08b)
Interest Expense / Debt = 0.60% (Interest Expense 47.2m / Debt 7.91b)
Taxrate = 21.0% (US default 21%)
NOPAT = 50.9m (EBIT 64.4m * (1 - 21.00%))
Current Ratio = 2.02 (Total Current Assets 446.1m / Total Current Liabilities 220.7m)
Debt / Equity = 2.04 (Debt 7.91b / totalStockholderEquity, last quarter 3.87b)
Debt / EBITDA = 23.65 (Net Debt 7.57b / EBITDA 320.1m)
Debt / FCF = 267.0 (Net Debt 7.57b / FCF TTM 28.4m)
Total Stockholder Equity = 3.92b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.82% (Net Income -88.3m / Total Assets 11.08b)
RoE = -2.25% (Net Income TTM -88.3m / Total Stockholder Equity 3.92b)
RoCE = 0.72% (EBIT 64.4m / Capital Employed (Equity 3.92b + L.T.Debt 5.07b))
RoIC = 0.68% (NOPAT 50.9m / Invested Capital 7.45b)
WACC = 3.32% (E(3.40b)/V(11.31b) * Re(9.94%) + D(7.91b)/V(11.31b) * Rd(0.60%) * (1-Tc(0.21)))
Discount Rate = 9.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 5.03%
[DCF Debug] Terminal Value 83.93% ; FCFF base≈68.9m ; Y1≈55.8m ; Y5≈38.7m
Fair Price DCF = N/A (negative equity: EV 1.19b - Net Debt 7.57b = -6.38b; debt exceeds intrinsic value)
EPS Correlation: 0.18 | EPS CAGR: -19.84% | SUE: -1.48 | # QB: 0
Revenue Correlation: -16.76 | Revenue CAGR: 13.85% | SUE: 4.0 | # QB: 9
EPS next Quarter (2026-03-31): EPS=-0.94 | Chg30d=+0.014 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=-2.71 | Chg30d=-0.028 | Revisions Net=-1 | Growth EPS=-22.6% | Growth Revenue=-6.8%
EPS next Year (2027-12-31): EPS=-1.97 | Chg30d=-0.022 | Revisions Net=-1 | Growth EPS=+27.5% | Growth Revenue=+1.9%